Aggrenox
NDC Package 0597-0001-60

The code 0597-0001-60 identifies a specific commercial package of 1 bottle in 1 carton / 60 capsule, extended release in 1 bottle of Aggrenox, labeled by Boehringer Ingelheim Pharmaceuticals Inc.. This is formulated for use and contains as the active substance.

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Boehringer Ingelheim Pharmaceuticals Inc. on December 19, 1999. The current certification is valid through March 31, 2021.

This medication is used to reduce the risk of stroke in patients who have had "mini-strokes" (transient ischemic attacks) or a previous stroke due to a blood clot and are at high risk for another stroke. It contains two medications: a very low dose of aspirin (25 milligrams per tablet) and dipyridamole in a slow-release form. Low-dose aspirin and dipyridamole are antiplatelet drugs that work to keep blood flowing to the brain by stopping platelets from clumping together. This helps prevent the platelets from forming blood clots, which can lodge in the brain and cause a certain type of stroke (ischemic stroke).

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00597000160. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.